Breast Cancer Clinical Trials in San Antonio, TX

Breast Cancer Clinical Trials in San Antonio, TX

View the best 10 breast cancer medical studies in San Antonio, Texas. Access promising new therapies by applying to a San Antonio-based Breast Cancer clinical trial.

Top rated breast cancer clinical trials in San Antonio, Texas

Here are the top 10 medical studies for breast cancer in San Antonio, Texas

Image of UCSF Helen Diller Family Comprehensive Cancer Center ( Site 0138) in San Francisco, United States.

Olaparib +1 More

PARP Inhibitor

Recruiting1 awardPhase 2
This trial is comparing the efficacy of two different treatments for triple negative breast cancer - olaparib plus pembrolizumab versus chemotherapy plus pembrolizumab. The primary hypotheses are that olaparib plus pembrolizumab will be superior to chemotherapy plus pembrolizumab in terms of progression-free survival and overall survival.
Image of Baptist MD Anderson Cancer Center in Jacksonville, United States.

Partial Breast Irradiation

Radiation

Recruiting1 awardPhase 2 & 3
This trial looks at how well a shorter, higher-dose radiation therapy works to treat early stage breast cancer. The cancer is only in the breast, and this treatment may have fewer side effects.
Image of University of Alabama at Birmingham in Birmingham, United States.

Pembrolizumab +1 More

Monoclonal Antibodies

Recruiting1 awardPhase 1 & 2
This trial is testing a new cancer treatment involving two drugs. It will study the side effects and if the drugs are effective in treating triple-negative breast cancer.
Image of University of Alabama at Birmingham in Birmingham, United States.

Gedatolisib +2 More

PI3K/mTOR Inhibitor

Recruiting2 awardsPhase 3
This trial tests a combination of drugs to treat advanced breast cancer after other treatments have stopped working.
Image of Highlands Oncology Group Main in Fayetteville, United States.

Alpelisib

Recruiting1 awardPhase 3
This trial is testing whether a new drug is effective and safe for people with a certain type of breast cancer.
Image of Northwestern Medicine Cancer Center in Warrenville, United States.

TOL2506

Hormone Therapy

Recruiting2 awardsPhase 3
This trial is testing a new drug to suppress ovarian function in premenopausal women with breast cancer. The study will also assess the safety of the drug in men with breast cancer.
Image of Kaiser Permanente - Oakland in Oakland, United States.

Letrozole +2 More

Hormone Therapy

Recruiting1 awardPhase 3
This trial will compare two treatments for breast cancer: giredestrant with palbociclib, and letrozole with palbociclib. The trial will measure how well the treatments work and how safe they are.
Image of Los Angeles County-USC Medical Center in Los Angeles, United States.

Ceralasertib +1 More

Enzyme Inhibitor

Recruiting1 awardPhase 1
This trial will find the best dose and safety of ceralasertib when given with trastuzumab deruxtecan to treat patients with solid tumors that have a change in the HER2 gene or protein.
Image of University of Alabama at Birmingham Cancer Center in Birmingham, United States.

Surgery +2 More

Procedure

Recruiting1 awardPhase 2 & 3
This trial is testing whether adding stereotactic radiosurgery and/or surgery to standard of care therapy is more effective in treating patients with limited metastatic breast cancer.
Image of Florida Cancer Specialists (St. Petersburg - St. Anthony's Professional Building) in Saint Petersburg, United States.

Inavolisib +2 More

PI3K Inhibitor

Recruiting0 awardsPhase 2 & 3
This trial will study whether adding inavolisib to palbociclib and fulvestrant improves outcomes for women with PIK3CA-mutant, hormone receptor-positive, HER2-negative breast cancer that has progressed after endocrine therapy.

Popular filter options for breast-cancer san-antonio trials

Phase 3 Clinical Trials

View 100 phase 3 medical studies.

Clinical Trials With No Placebo

View 100 medical studies that do not have a placebo group.

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.